Should You Invest In GW Pharmaceuticals Plc?

Discuss investment strategies, review market research and real-time updates


621,176 GW Pharmaceuticals Plc positions opened on eToro

GW Pharmaceuticals Plc
150.56 -1.51%
99.14 -1.39%
41.64 0.43%

GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, UK. It is a biopharmaceutical company, which is currently focused on developing and marketing cannabinoid-based medicines for a range of disease areas. Key products include Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD), and Sativex (nabiximols), which is used for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Follow the GWPH instrument to learn all about the latest news and developments.

Read More

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.


Volatility means opportunity! Watch price changes reflect directly onto your portfolio


Start trading within minutes - no physical purcase delays


Benefit from falling prices as well as rising prices. Buy or sell instantly

Start Investing
Zero commission means that no broker fee will be charged when opening or closing the position and does not apply to short or leveraged positions. Other fees apply including FX fees on non-USD deposits and withdrawals. Your capital is at risk. For more information, click it